{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:48:22Z","timestamp":1760852902893,"version":"3.41.2"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[1999,11,1]],"date-time":"1999-11-01T00:00:00Z","timestamp":941414400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[1999,11,1]],"date-time":"1999-11-01T00:00:00Z","timestamp":941414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[1999,11]]},"DOI":"10.1023\/a:1018945713623","type":"journal-article","created":{"date-parts":[[2003,2,19]],"date-time":"2003-02-19T17:07:13Z","timestamp":1045674433000},"page":"1687-1693","source":"Crossref","is-referenced-by-count":23,"title":["Aryl Ester Prodrugs of Cyclic HPMPC. I: Physicochemical Characterization and In Vitro Biological Stability"],"prefix":"10.1007","volume":"16","author":[{"given":"Reza","family":"Oliyai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeng-Pyng","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cathy M.","family":"Sueoka-Lennen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth C.","family":"Cundy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murty N.","family":"Arimilli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert J.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William A.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"303723_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/095632029700800101","volume":"8","author":"L. Naesens","year":"1997","unstructured":"L. Naesens, R. Snoeck, J. Balzarini, J. Neyts, and E. De Clercq. HPMPC (cidofovir), PMEA (adefovir) and related acylic nucleoside phosphonate analogues: A review of their pharmacology and clinical potential in the treatment of viral infections. Antiviral Chem. Chemother.\n8:1\u201323 (1997).","journal-title":"Antiviral Chem. Chemother."},{"key":"303723_CR2","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1177\/095632029600700301","volume":"7","author":"M. J. M. Hitchcock","year":"1996","unstructured":"M. J. M. Hitchcock, H. S. Jaffe, J. C. Martin, and R. J. Stagg. Review\u2014Antiviral portrait series. Cidofovir, a new agent with potent anti-herpesvirus activity. Antiviral Chem. Chemother.\n7:115\u2013127 (1996).","journal-title":"Antiviral Chem. Chemother."},{"key":"303723_CR3","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S0090-9556(25)07424-0","volume":"24","author":"K. C. Cundy","year":"1996","unstructured":"K. C. Cundy, A. M. Bidgood, G. Lynch, J.-P. Shaw, L. Griffin, and W. A. Lee. Pharmacokinetics, bioavailability, metabolism, and tissue distribution of cidofovir (HPMPC) and cyclic HPMPC in rats. Drug Metab. Disp.\n24:745\u2013752 (1996).","journal-title":"Drug Metab. Disp."},{"key":"303723_CR4","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1128\/AAC.39.11.2401","volume":"39","author":"K. C. Cundy","year":"1995","unstructured":"K. C. Cundy, P. Barditch-Crovo, R. E. Walker, A. C. Coller, D. Ebeling, J. Toole, and H. S. Jaffe. Clinical pharmacokinetics of Adefovir in human immunodeficiency virus type 1-infected patients. Antimicr. Agents Chemother.\n39:2401\u20132405 (1995).","journal-title":"Antimicr. Agents Chemother."},{"key":"303723_CR5","first-page":"361","volume":"25","author":"J.-P. Shaw","year":"1997","unstructured":"J.-P. Shaw, M. S. Louie, V. V. Krishnamurthy, M. A. Arimilli, R. J. Jones, Alison M. Bidgood, W. A. Lee, and K. C. Cundy. Pharmacokinetics and metabolism of selected prodrugs of PMEA in rats. Drug Metab. Disp.\n25:361\u2013366 (1997).","journal-title":"Drug Metab. Disp."},{"key":"303723_CR6","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1023\/A:1012108719462","volume":"12","author":"J.-P. Shaw","year":"1997","unstructured":"J.-P. Shaw, C. M. Sueoka, R. Oliyai, W. A. Lee, M. N. Arimilli, C. U. Kim, and K. C. Cundy. Metabolism and pharmacokinetics of novel oral prodrugs of 9-[(R)-2-(phosphonomethoxy)propyl] adenine (PMPA) in dogs. Pharm. Res.\n12:1824\u20131829 (1997).","journal-title":"Pharm. Res."},{"key":"303723_CR7","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0169-409X(95)00111-J","volume":"19","author":"J. P. Krise","year":"1996","unstructured":"J. P. Krise and V. J. Stella. Prodrugs of phosphates, phosphonates, and phosphinates. Adv. Drug Del. Rev.\n19:287\u2013310 (1996).","journal-title":"Adv. Drug Del. Rev."},{"key":"303723_CR8","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1086\/514057","volume":"176","author":"P. Barditch-Crovo","year":"1997","unstructured":"P. Barditch-Crovo, J. Tool, C. W. Hendrix, K. C. Cundy, H. S. Jaffe, and P. S. Lietman. Anti-juman immunodeficiency virus (HIV) activity, safety, and pharmacokinetics of Adefovir Dipivoxil (9-2-[bis-pivalotloxymethyl)-phosphonylmethoxyethyl]adenine) in HIV-infected patients. J. Infect. Dis.\n176:406\u2013413 (1997).","journal-title":"J. Infect. Dis."},{"key":"303723_CR9","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1128\/AAC.38.10.2387","volume":"38","author":"N. Bischofberger","year":"1994","unstructured":"N. Bischofberger, M. J. M. Hitchcock, M. S. Chen, K. C. Cundy, D. Barkhimer, K. M. Kent, S. A. Lacy, W. A. Lee, Z.-H. Li, M. Louie, D. B. Mendel, D. S. Smee, and J. L. Smith. 1-[((S)-2-Hydroxy-2-Oxo-1,4,2-Dioxaphosphorinan-5-yl)Methyl]Cytosine, an intracellular prodrug for (S)-1-(3-Hydroxy-2-(Phosphonylmethoxypropyl)Cytosine with improved therapeutic index in vivo. Antimicr. Agents Chemother.\n38:2387\u20132391(1994).","journal-title":"Antimicr. Agents Chemother."},{"key":"303723_CR10","doi-asserted-by":"crossref","first-page":"A358","DOI":"10.1016\/0166-3542(95)94952-X","volume":"26","author":"M. J. M. Hitchcock","year":"1995","unstructured":"M. J. M. Hitchcock, S. A. Lacy, J. R. Lindsey, and E. R. Kern. The cyclic congener of cidofovir has reduced nephrotoxicity in three species. Antiviral Res.\n26:A358 (1995).","journal-title":"Antiviral Res."},{"key":"303723_CR11","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1128\/AAC.41.3.641","volume":"41","author":"D. B. Mendel","year":"1997","unstructured":"D. B. Mendel, T. Cihlar, K. Moon, and M. S. Chen. Cyclic HPMPC is converted to cidofovir by an intracellular cyclic CMP phosphodiesterase. Antimicr. Agents Chemother.\n41:641\u2013646 (1997).","journal-title":"Antimicr. Agents Chemother."},{"key":"303723_CR12","doi-asserted-by":"crossref","first-page":"A340","DOI":"10.1016\/0166-3542(95)94916-P","volume":"26","author":"W. A. Lee","year":"1995","unstructured":"W. A. Lee, J.-P. Shaw, A. M. Bidgood, G. Lynch, E. Eisenberg, and K. C. Cundy. Tissue distribution and bioavailability of cyclic HPMPC, an intracellular prodrug of HPMPC. Antiviral Res.\n26:A340 (1995).","journal-title":"Antiviral Res."},{"key":"303723_CR13","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1021\/bi00625a011","volume":"16","author":"S. Kelly","year":"1997","unstructured":"S. Kelly and L. G. Butler. Enzymic hydrolysis of phosphonate esters. Reaction mechanism of intestinal 5\u2032-nucleotide phosphodiesterase. Biochemistry\n16:1102\u20131104 (1997).","journal-title":"Biochemistry"},{"key":"303723_CR14","doi-asserted-by":"crossref","first-page":"4983","DOI":"10.1021\/bi00693a030","volume":"14","author":"S. Kelly","year":"1975","unstructured":"S. Kelly, D. E. Dardinger, and L. G. Butler. Hydrolysis of phosphonate esters catalyzed by 5\u2032-nucleotide phosphodiesterase. Biochemistry\n14:4983\u20134988 (1975).","journal-title":"Biochemistry"},{"key":"303723_CR15","doi-asserted-by":"crossref","first-page":"4109","DOI":"10.1021\/jm9600757","volume":"39","author":"S. Khamnei","year":"1996","unstructured":"S. Khamnei and P. F. Torrence. Neighboring group catalysis in the design of nucleotide prodrugs. J. Med. Chem.\n39:4109\u20134115 (1996).","journal-title":"J. Med. Chem."},{"key":"303723_CR16","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3109\/03602538909103549","volume":"20","author":"G. Powis","year":"1989","unstructured":"G. Powis. The use of human liver for foreign compound metabolism and toxicity studies. Drug Metab. Rev.\n20:379\u2013394 (1989).","journal-title":"Drug Metab. Rev."},{"key":"303723_CR17","unstructured":"M. N. Arimilli, R. J. Jones, and E. Prisbe. Nucleotide analogs. U.S. Patent 5,717,095 (1998.)"},{"key":"303723_CR18","doi-asserted-by":"crossref","first-page":"5490","DOI":"10.1021\/ja00278a020","volume":"108","author":"I. M. Kovach","year":"1986","unstructured":"I. M. Kovach, M. Larson, and R. L. Schowen. Catalytic recruitment in the inactivation of serine protease by phosphonate esters. Recruitment of acid-base catalysis. J. Am. Chem. Soc.\n108:5490\u20135495 (1986).","journal-title":"J. Am. Chem. Soc."},{"key":"303723_CR19","doi-asserted-by":"crossref","first-page":"8128","DOI":"10.1021\/bi00192a018","volume":"33","author":"Q. Zhao","year":"1994","unstructured":"Q. Zhao, I. M. Kovach, A. Bencsura, and A. Papathanassiu. Enantioselective and reversible inhibition of Trypsin and \u03b1-Chymotrypsin by phosphonate esters. Biochemistry\n33:8128\u20138138 (1994).","journal-title":"Biochemistry"},{"key":"303723_CR20","doi-asserted-by":"crossref","first-page":"5187","DOI":"10.1016\/S0040-4020(01)87694-8","volume":"43","author":"J.-W. Chang","year":"1987","unstructured":"J.-W. Chang and D. G. Gorenstein. Stereoelectronic effects on the conformation and kinetics of nucleophilic displacement reactions in epimeric six-membered ring phosphonate diesters. Tetrahedron. 43:5187\u20135196 (1987).","journal-title":"Tetrahedron"},{"key":"303723_CR21","doi-asserted-by":"crossref","first-page":"5894","DOI":"10.1021\/ja00409a046","volume":"103","author":"R. Rowell","year":"1981","unstructured":"R. Rowell and D. G. Gorenstein. Multiple structure-reactvity correlations in the hydrolysis of epimeric 2-(aryloxy)-2-oxydioxa-phosphorinanes. Stereoelectronic effects. J. Am. Chem. Soc.\n103:5894\u20135902 (1981).","journal-title":"J. Am. Chem. Soc."},{"key":"303723_CR22","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1021\/cr60259a002","volume":"69","author":"S. W. Benson","year":"1969","unstructured":"S. W. Benson, F. R. Cruickshank, D. M. Golden, G. R. Haugen, H. E. O'Neal, A. S. Rodgers, R. Shaw, and R. Walsh. Additivity rules for the estimation of thermodymamical properties. Chemical Rev.\n69:279\u2013324 (1969).","journal-title":"Chemical Rev."},{"key":"303723_CR23","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1021\/cr60230a001","volume":"64","author":"J. R. Cox","year":"1964","unstructured":"J. R. Cox and O. B. Ramsay. Mechanism of nucleophilic substitution in phosphate esters. Chem. Rev.\n64:317\u2013352 (1964).","journal-title":"Chem. Rev."},{"key":"303723_CR24","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1021\/ar50003a002","volume":"1","author":"F. H. Westheimer","year":"1968","unstructured":"F. H. Westheimer. Pseudo-Rotation in the hydrolysis of phosphate esters. Acc. Chem. Res.\n1:70\u201378 (1968).","journal-title":"Acc. Chem. Res."},{"key":"303723_CR25","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1128\/AAC.42.3.687","volume":"42","author":"K. C. Cundy","year":"1998","unstructured":"K. C. Cundy, C. Sueoka, G. R. Lynch, L. Griffin, W. A. Lee, and J.-P. Shaw. Pharmacokinetics and bioavailability of the antihuman immunodeficiency virus nucleotide analog PMPA in dogs. Antimicr. Agents Chemother.\n42:687\u2013690 (1998).","journal-title":"Antimicr. Agents Chemother."}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1018945713623.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1018945713623\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1018945713623.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T07:46:10Z","timestamp":1754034370000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1018945713623"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,11]]},"references-count":25,"journal-issue":{"issue":"11","published-print":{"date-parts":[[1999,11]]}},"alternative-id":["303723"],"URL":"https:\/\/doi.org\/10.1023\/a:1018945713623","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"type":"print","value":"0724-8741"},{"type":"electronic","value":"1573-904X"}],"subject":[],"published":{"date-parts":[[1999,11]]}}}